The global digital genome market is anticipated to grow at a considerable CAGR of 8.7% during the forecast period. The key factors that are contributing to the market growth are increasing funding activities and grants by the government, research institutes, and companies operating in the market among others. Thus. owing to the increasing funding activated for digitalization is influencing the positive growth of the digital genome market. For instance,
Browse the full report description of “Digital Genome Market Size, Share & Trends Analysis Report by Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing & Analysis Software, And Sample Preparation Instruments), by Application (Microbiology, Reproductive & Genetic, Transplantation and Agriculture, Forensics, and Research and Development), and by End-User (Academic Research Institutes, Diagnostics & Forensic Labs, Hospitals, and Bio-pharmaceutical Companies) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/digital-genome-market
• In July 2022, Ultima Genomics raised a $600 million investment community for a low-cost sequencing platform that delivers the $100 genome. The company is set to develop a new era in genomics by developing a “fundamentally new sequencing architecture which includes different approaches to flow cell engineering, sequencing chemistry, and machine learning.
• In September 2021, the Rockefeller Foundation in collaboration with 20 organizations from the public, private, and non-profit sectors funded $20 million by strengthening organizations' abilities to sequence and share genomic information and other data rapidly. These newly funded grants have expanded country and regional capacity for sequencing the genomes of pathogens in sub-Saharan Africa, India, and the US.
• In September 2019, the National Institutes of Health (NIH) granted approximately $29.5 million for advancing the reference sequence to generate and maintain the most comprehensive reference sequence of the human genome. This was maintained by the National Human Genome Research Institute (NHGRI), which develops a multi-genome reference sequence that is as universal and complete and represents 350 genomes from the human population.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Products
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Agilent technologies, inc., Bionano genomics inc., Illumina, inc., Intellia Therapeutics, Inc. PerkinElmer Inc., Thermo Fisher Scientific Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Digital Genome Market Report Segment
By Products
By Application
By End-User
Global Digital Genome Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/digital-genome-market